GE Healthcare using AI for COVID-19 chest x-rays

By William Smith
GE Healthcare has announce d a suite of AI algorithms intended to lessen the clinical strain caused by COVID-19...

GE Healthcare has announce d a suite of AI algorithms intended to lessen the clinical strain caused by COVID-19.

GE Healthcare is a subsidiary of General Electri c, the American conglomerate, and is focused on the healthcare and pharmaceutical industry.

The eight algorithms, from Lunit INSIGHT CXR, are capable of analysing chest x-rays to find abnormalities such as tuberculosis, lung nodules and pneumonia, an indicator of COVID-19 and a key cause of mortality in those who have contracted coronavirus.

In a press release, Kieran Murphy, President and CEO, GE Healthcare, said: “The launch of our Thoracic Care Suite is a part of GE Healthcare’s larger effort to help ensure clinicians and partners on the front lines have the equipment they need to quickly diagnose and effectively treat COVID-19 patients. 

“The pandemic has proven that data, analytics, AI and connectivity will only become more central to delivering care. For GE Healthcare, that means continuing to advance intelligent health and providing innovative technologies. This new offering is the latest example of how x-ray and AI can uphold the highest standard of patient care amidst the most modern of disease threats.”

GE Healthcare highlighted the urgency of automation in the face of increasingly large numbers of infected individuals, threatening to overwhelm healthcare facilities and professionals. Radiologists face a particular squeeze to process and understand x-rays, with GE saying that even prior to the ongoing pandemic, with approximately 1.44 billion chest x-ray exams happening per year.

“Clinicians are looking for clinically proven methods to help identify symptoms early and determine which patients are at higher risk of complications and need to be actively monitored,” saidProfessor Fergus Gleeson, Consultant Radiologist, Professor of Radiology at the University of Oxford. “AI can help identify these distinctions and enable hospital resources to be targeted to those that will need them whilst in hospital and following discharge.”

(Image: GE Healthcare)

Share

Featured Articles

The Merck Group: Pharma's History & Innovation in India

Welcome back to part two of our exploration of The Merck Group's history and investment in China and India, with this part focusing on innovation in India

How CVS Health is Rising to the Omnichannel Challenge

US healthcare company CVS Health is reshaping its supply chain to meet the omnichannel needs of its customers

Kinaxis: Pharma Seeing Euro-wide Supply Chain Challenges

Supply chain specialist Kinaxis says UK pharma still recovering from Brexit and pandemic, and that Europe also seeing medicines value chain problems

Healthcare Digital Transformations Stymied by Data Silos

Digital Healthcare

McKinsey: Brain Health Underfunding 'a Global Concern'

Digital Healthcare

Endometriosis Linked to Heart Attacks & Strokes

Medical Devices & Pharma